Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lymphocytic lymphoma
ADR ID BADD_A05106
ADR Hierarchy
01      Blood and lymphatic system disorders
01.12      Lymphomas NEC
01.12.01      Lymphomas unspecified NEC
01.12.01.002      Lymphocytic lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.20      Lymphomas NEC
16.20.01      Lymphomas unspecified NEC
16.20.01.002      Lymphocytic lymphoma
Description A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. [MeSH]
MedDRA Code 10052178
MeSH ID D015451
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Lymphocytic lymphoma | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphocytic, Chronic, B Cell | Lymphoma, Lymphocytic, Well-Differentiated | Lymphoma, Lymphoplasmacytoid, CLL | Lymphoma, Small Lymphocytic | Lymphocytic Lymphoma, Small | Lymphocytic Lymphomas, Small | Lymphomas, Small Lymphocytic | Small Lymphocytic Lymphoma | Small Lymphocytic Lymphomas | Lymphoma, Small Lymphocytic, Plasmacytoid | Lymphoma, Small-Cell | Lymphoma, Small Cell | Lymphomas, Small-Cell | Small-Cell Lymphomas | Lymphoplasmacytoid Lymphoma, CLL | CLL Lymphoplasmacytoid Lymphoma | CLL Lymphoplasmacytoid Lymphomas | Lymphoma, CLL Lymphoplasmacytoid | Lymphomas, CLL Lymphoplasmacytoid | Lymphoplasmacytoid Lymphomas, CLL | Small-Cell Lymphoma | Small Cell Lymphoma | Lymphoblastic Leukemia, Chronic | Chronic Lymphoblastic Leukemia | Chronic Lymphoblastic Leukemias | Leukemias, Chronic Lymphoblastic | Lymphoblastic Leukemias, Chronic | Lymphocytic Leukemia, Chronic | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia, Chronic, B-Cell | Lymphocytic Lymphoma | Lymphocytic Lymphomas | Lymphomas, Lymphocytic | Lymphocytic Lymphoma, Diffuse, Well Differentiated | Lymphocytic Lymphoma, Diffuse, Well-Differentiated | Lymphocytic Lymphoma, Well Differentiated | Lymphocytic Lymphoma, Well-Differentiated | Lymphocytic Lymphomas, Well-Differentiated | Lymphoma, Well-Differentiated Lymphocytic | Lymphomas, Well-Differentiated Lymphocytic | Well-Differentiated Lymphocytic Lymphoma | Well-Differentiated Lymphocytic Lymphomas | Lymphoma, Lymphocytic | Lymphoma, Lymphocytic, Diffuse, Well Differentiated | B-Cell Chronic Lymphocytic Leukemia | B Cell Chronic Lymphocytic Leukemia | B-Cell Leukemia, Chronic | B Cell Leukemia, Chronic | B-Cell Leukemias, Chronic | Chronic B-Cell Leukemia | Chronic B-Cell Leukemias | Leukemia, Chronic B-Cell | Leukemias, Chronic B-Cell | B-Cell Malignancy, Low-Grade | B-Lymphocytic Leukemia, Chronic | B Lymphocytic Leukemia, Chronic | B-Lymphocytic Leukemias, Chronic | Chronic B-Lymphocytic Leukemia | Chronic B-Lymphocytic Leukemias | Leukemia, Chronic B-Lymphocytic | Leukemias, Chronic B-Lymphocytic | Chronic Lymphocytic Leukemia | Chronic Lymphocytic Leukemias | Lymphocytic Leukemias, Chronic | Diffuse Well-Differentiated Lymphocytic Lymphoma | Diffuse Well Differentiated Lymphocytic Lymphoma | Disrupted In B-Cell Malignancy | Leukemia, B Cell, Chronic | Leukemia, B-Cell, Chronic | Leukemia, Chronic Lymphatic | Leukemia, Chronic Lymphocytic | Leukemia, Chronic Lymphocytic, B-Cell | Leukemia, Lymphoblastic, Chronic | Leukemia, Lymphocytic, Chronic | Lymphoma, Lymphocytic, Diffuse, Well-Differentiated | Lymphoma, Lymphocytic, Well Differentiated
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00577Dantrolene sodium--
The 1th Page    1    Total 1 Pages